[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Ivermectin in Africa and Brazil", "description": "Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching (Brazil)\n\nhttps://www.cureus.com/articles/82162-ivermectin-prophylaxis-used-for-covid-19-a-citywide-prospective-observational-study-of-223128-subjects-using-propensity-score-matching\n\nBackground\n\nIvermectin has demonstrated different mechanisms of action, coronavirus infection and COVID-19-related comorbidities. \n\nProphylaxis combined with the known safety profile of ivermectin\n\nStudy to evaluate the impact of regular ivermectin use on subsequent COVID-19 infection and mortality rates.\n\nProspective, July 2020 and December 2020\n\nInviting the entire population of Itaja\u00ed to a medical visit to enroll in the program,\n\nivermectin was offered as an optional treatment to be taken for two consecutive days every 15 days at a dose of 0.2 mg/kg/day. \n\nStudy analysis consisted of comparing ivermectin users with non-users using cohorts\n\nResults\n\n223,128 citizens of Itaja\u00ed considered\n\n159,561 included in the analysis\n\n113,845 (71.3%) regular ivermectin users\n\n45,716 (23.3%) non-users\n\nOf these\n\n4,311 ivermectin users were infected, (3.7% infection rate)\n\n3,034 non-users (6.6% infection rate)\n\nA 44% reduction in COVID-19 infection rate\n\nRisk ratio (RR), 0.56\n\nThe regular use of ivermectin led to a 68% reduction in COVID-19 mortality\n\nDeaths\n\n25 (0.8%) deaths in the ivermectin group\n\n79 (2.6%) among ivermectin non-users\n\nRR, 0.32\n\np less than 0.0001\n\nWhen adjusted for residual variables, reduction in mortality rate was 70%\n\nThere was a 56% reduction in hospitalization rate\n\n44 in the ivermectin group\n\n99 in non ivermectin users\n\nAfter adjustment for residual variables, reduction in hospitalization rate was 67%\n\np less than 0.0001\n\nConclusion \n\nIn this large study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.", "link": "https://www.youtube.com/watch?v=Gz4adJXLHgA", "date_published": "2022-03-14 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "The Natural Doctor", "description": "Links to Dr Eccles, https://thenaturaldoctor.org/\n\nhttps://thenaturaldoctor.org/wp-content/uploads/2020/04/Coronavirus-and-Vitamin-D-and-C.pdf\n\nThis video is for educational purposes only. It must never replace individual clinical judgement from your own health care provider. No media-based material on this channel is suitable for using as professional medical advice. All comments are also for educational purposed only and must never replace advice from your own health care provider.", "link": "https://www.youtube.com/watch?v=ksP2EuUQXeo", "date_published": "2022-03-14 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]